Abstract: Despite the ubiquitous role of ATP-binding cassette (ABC) importers in nutrient uptake, only the Escherichia coli maltose and vitamin B 12 ABC transporters have been structurally characterized in multiple conformations relevant to the alternating access transport mechanism. To complement our previous structure determination of the E. coli MetNI methionine importer in the inward facing conformation Science 321, 250-253), we have explored conditions stabilizing the outward facing conformation. Using two variants, the Walker B E166Q mutation with ATP+EDTA to stabilize MetNI in the ATPbound conformation and the N229A variant of the binding protein MetQ, shown in this work to disrupt methionine binding, a high affinity MetNIQ complex was formed with a dissociation constant measured to be 27 nm. Using wild type MetQ containing a co-purified methionine (for which the crystal structure is reported at 1.6 Å resolution), the dissociation constant for complex formation with MetNI is measured to be ∼40-fold weaker, indicating that complex formation lowers the affinity of MetQ for methionine by this amount. Preparation of a stable MetNIQ complex is an essential step towards the crystallographic analysis of the outward facing conformation, a key intermediate in the uptake of methionine by this transport system.
Introduction
Many different transporters are encoded in the genomes of microorganisms to accommodate the diversity of molecules they need to acquire from the environment. For example, ∼10% of the Escherichia coli genome has been classified as participants in transport processes, of which approximately half are ATP-binding cassette (ABC) transporters (Blattner et al., 1997; Linton and Higgins, 1998) . ABC transporters consist of four domains: two transmembrane domains (TMDs) that form the translocation pathway, and two nucleotide-binding domains (NBDs) that use the energy from ATP binding and hydrolysis to fuel transport (reviewed in Ames et al., 1992; Higgins, 1992; Holland et al., 2003; Locher, 2008; Oldham et al., 2008; Rees et al., 2009 ). The transport mechanism utilizes an alternating access model (Widdas, 1952; Jardetsky, 1966) that involves the interconversion of two distinct conformations during the transport cycle, inward facing and outward facing, where the translocation pathway is open to the cytoplasm and periplasm, respectively. ABC importers require an additional component for transport, namely substrate-binding proteins (SBP), located in the periplasm of Gram-negative bacteria or tethered to the membrane in Gram-positive bacteria and archaea, to bind and deliver substrates to their cognate transporter (Ames et al., 1992; Wilkinson and Verschueren, 2003; Berntsson et al., 2010) . Structures of transporters in complex with their binding proteins Hvorup et al., 2007; Oldham et al., 2007; Korkhov et al., 2012) have been instrumental in defining basic features of the transport cycle, including the two best structurally characterized ABC importers, the Type I maltose uptake system, MalFGK 2 (Oldham and Chen, 2011) and the Type II vitamin B 12 uptake system, BtuCD (Korkhov et al., 2014) . Despite the common nucleotide-dependent engine driving translocation, binding protein-transporter interactions can vary significantly, reflecting mechanistic diversity between various ABC importers (Lewinson et al., 2010) .
In this work, we focus on the E. coli high affinity methionine uptake system (Kadner, 1974) , comprising the MetNI transporter and its cognate binding protein, MetQ (Gál et al., 2002; Merlin et al., 2002) . Currently, only the inward facing conformational state of MetNI has been solved crystallographically Johnson et al., 2012) . To build a comprehensive model for MetNI transport, we sought to identify conditions under which a stable transporter-binding protein complex can form. A challenge in working with E. coli MetNI is that while methionine is the transported ligand, it also functions as an allosteric effector inhibiting methionine uptake at sufficiently high intracellular concentrations (Kadner, 1975) . This phenomenon of transinhibition is mediated by methionine functioning as a noncompetitive inhibitor of ATPase activity (Yang and Rees, 2015) by binding to a cytoplasmic regulatory domain of the ABC subunit MetN to stabilize MetNI in an inward facing conformation incapable of hydrolyzing ATP Johnson et al., 2012) . Further complicating the analysis is the observation of a co-purifying methionine in crystal structures of methionine-binding SBPs (Deka et al., 2004; Williams et al., 2004; Yang et al., 2009; Yu et al., 2011) , including the E. coli MetQ structure (Kadaba, 2008 ).
Here we demonstrate that formation of a high affinity MetNIQ complex requires an ATP-bound state of MetNI and an unliganded form of MetQ. Preparation of this complex is facilitated by the identification of mutations in MetQ that abolish methionine binding. The influence of methionine on complex formation between ATP-stabilized MetNI and MetQ is quantitated by titrating fluorescently labeled MetQ with varying concentrations of MetNI. From these measurements, dissociation constants of 1100±300 and 27±9 nm are found for methionine-bound and methionine-free MetQ, respectively, establishing that ligand-free MetQ can form a stable complex with the ATP-bound form of MetNI. Our isolation of a stable MetNIQ complex is an essential step towards the crystallographic analysis of the outward facing conformation, a key intermediate in the uptake of methionine by this transporter.
Results and discussion
To better understand the mechanism of the methionine transport system, we sought to identify conditions under which the MetNI transporter forms a stable complex with the cognate periplasmic binding protein MetQ. Previous studies demonstrated that wild type MetNI and wild type MetQ interact weakly in the absence of nucleotide (K d = 7.4 × 10 -5 m) and a stable complex under these conditions could not be detected by gel filtration chromatography (Lewinson et al., 2010) . Based on studies of the maltose system (Chen et al., 2001) , we hypothesized that the MetNI transporter binds MetQ with the highest affinity in an ATP-bound state. To maintain the ATP-bound state, an ATPase deficient form was generated by substitution of Glu 166 in the Walker B motif of MetN with Gln (E166Q), in combination with the use of the chelator EDTA with ATP to remove the catalytically essential Mg
2+
. Mutation of the Walker B Glu is commonly used to inhibit hydrolysis, but not binding, of ATP by ABC transporters (Moody et al., 2002) . ATPase assays show that the E166Q mutation results in an ∼20-fold reduction in ATPase activity (data not shown). All subsequent experiments in this study were conducted using this mutant transporter, denoted E166Q MetNI, in the presence of saturating amounts of ATP+EDTA (1 mm ATP and 1 mm EDTA) to mimic the ATPbound state.
We first tested for complex formation by incubating E166Q MetNI with wild type MetQ and saturating amounts of ATP+EDTA at different ratios of transporter to binding protein ( Figure 1A ). Mixtures of either 1:1.25 or 1:6 (MetNI: MetQ) were injected onto a gel filtration column ( Figure 1A) , and the peak fraction was analyzed by blue native PAGE ( Figure 1B ) (BN PAGE; Reisinger and Eichacker, 2006) to evaluate the extent of complex formation. Despite an excess of MetQ, incomplete complex formation was observed in both cases, as established by the slight shift in the peaks of MetNI after incubation with its binding protein at different molar ratios ( Figure 1A ), shown by blue and green traces compared to that of MetNI alone (black trace). This finding is confirmed by the presence of two bands on BN PAGE ( Figure 1B, lanes 2 and 3) , the upper one corresponding to the MetNIQ complex and the lower one to free transporter by comparison to E166Q MetNI alone ( Figure 1B, lane 1) .
Wild type MetQ contains a co-purifying methionine identified in the crystal structures of MetQ homologs Staphylococcus aureus lipoprotein-9 (PDB entry 1P99, Williams et al., 2004) , Treponema pallidum Tp32 (PDB entry 1XS5, Deka et al., 2004) , E. coli MetQ (Kadaba, 2008) , Neisseria meningitidis (PDB 3IR1, Yang et al., 2009 ), structure and binding site for L-methionine are illustrated in Figure 2 for E. coli MetQ refined at 1.6 Å resolution (PDB entry 4YAH, see Methods). An extensive hydrogen bond/salt bridge network between protein side chains and the methionine α-amino and carboxyl groups likely contributes to the tight binding of ligand to MetQ. Groups interacting with the α-carboxyl group of methionine include the side chains of Arg144, Asn202, and a buried water, while the α-amino group interacts with the side chains of Glu42 and Thr204 and two buried waters. Significantly, the side chain of Asn229 forms two hydrogen bonds (one each) to the α-amino and carboxyl groups of the L-methionine. The side chain of the bound L-methionine fits in a pocket surrounded by the aromatic side chains of Tyr69, Phe86, His88, and Tyr91. Aromatic interactions with the methionine side chain are not uncommon (Pal and Chakrabarti, 2001) , particularly the interaction observed with the ligand SD packed against the plane of His88 such that the CG-SD bond is oriented towards the NE2 atom of His88.
To evaluate the contribution of L-methionine binding to MetQ to the stability of the MetNIQ complex, it is necessary to prepare ligand-free MetQ. While methionine can be removed from MetQ by an unfolding/refolding process (Deka et al., 2004) , we developed an alternative approach of using alanine-scanning mutagenesis to identify MetQ mutants that disrupt the binding of L-methionine. Residues in the MetQ binding pocket in contact with methionine were mutated to alanine ( Figures 2B and 3) , with the exception of Glu42 that was substituted with Gln (E42Q) because the E42A mutant aggregated. To test for L-methionine binding, we unfolded MetQ in 6 m guanidineHCl to release any co-purified L-methionine (Deka et al., 2004) , and then refolded the protein in the presence of L-selenomethionine. Selenium content was measured by inductively coupled plasma mass spectrometry (ICP-MS), and the molar ratio of selenium to MetQ was calculated (Figure 3) . Mutation of Glu42 to Gln (E42Q) and Asn229 to Ala (N229A) significantly decreased the binding affinity of MetQ to selenomethionine, while substitutions at other residues had relatively little effect on selenomethionine binding. The E42Q and N229A MetQ mutants, identified in this screen as unable to bind selenomethionine (and presumably methionine), were then tested for complex formation with E166Q MetNI in the presence of ATP+EDTA. The E42Q mutant was unable to form a complex with its cognate transporter (data not shown). When N229A MetQ was incubated with E166Q MetNI in the presence of ATP+EDTA, however, a stable complex formation was indicated by a distinct shift in the MetNI gel filtration peak after the reaction, shown by the red trace ( Figure 1A ). This stoichiometric complex formation was also observed by BN PAGE ( Figure 1B, lane 4) . This result contrasts with the mixture of free and complexed species observed when E166Q MetNI is incubated with wild type liganded MetQ under comparable conditions ( Figure 1B, lanes 2 and 3) . Based on these results, the N229A MetQ variant was used in this study to mimic methionine-free MetQ.
To quantify the binding affinity of E166Q MetNI for MetQ in either the bound or unliganded state, we measured the dissociation constants for complex formation from titration curves conducted with fluorescently labeled MetQ on a Monolith NT.115 Microscale Thermophoresis Instrument (NanoTemper Technologies GmbH). Wild type and N229A MetQ were labeled with Cy3-maleimide and titrated with varying concentrations of E166Q MetNI in the presence of ATP+EDTA. The fraction of MetQ in complex with E166Q MetNI was calculated from fluorescent intensity values (see materials and methods). The affinity of L-methionine-bound wild type MetQ for E166Q MetNI was ∼40-fold weaker than that for unliganded N229A MetQ to E166Q MetNI (Figure 4) . The calculated K d of 1100±300 nm for wild type MetQ represents a lower limit for the affinity, as saturating amounts of E166Q MetNI were prone to aggregation. The K d for N229A MetQ was determined to be 27±9 nm. This difference in affinity is qualitatively consistent with our gel filtration ( Figure 1A ) and BN PAGE results ( Figure 1B) .
We have identified conditions promoting stable complex formation between MetNI and MetQ through the use of two mutations (the E166Q variant in the Walker B motif of MetN that reduces ATP hydrolysis, and the N229A variant of MetQ that disrupts methionine binding) and the presence of ATP+EDTA to reduce the concentration of Mg 2+ critical for ATP hydrolysis. These conditions should stabilize the ATP-bound form of MetNI, corresponding to the outward facing conformation of a Type I ABC transporter (Oldham and Chen, 2011 ). An unexpected feature of the MetNI system is that the use of ligand-free MetQ resulted in stable complex formation, in contrast to the maltose transporter system where formation of a stable transporter-SBP complex required the presence of the transported substrate (Chen et al., 2001; Oldham et al., 2007) . In the absence of ATP, a 'pre-translocation' species has also been crystallized with substrate-loaded SBP and an inward facing conformation of the transporter for the transporter in nanodiscs with AMPPNP (K d ∼80 nm and ∼400 nm in the absence or presence of maltose, respectively; Bao and Duong, 2012 ). An additional complication with the MetNI transporter is that methionine is both a transported ligand and an allosteric inhibitor of transport, and these effects will need to be distinguished from the contributions of the liganded state of MetQ to the observed kinetics. The development of a detailed molecular transport mechanism will require analysis of conformational dynamics of the type recently described for the GlnPQ uptake system (Gouridis et al., 2015) . The structural analysis of stable forms of ABC transporters such as the MetNIQ complex detailed here will provide crucial reference states for these future mechanistic studies.
Materials and methods

Cloning, expression and purification of MetQ
The metNIQ operon was amplified from E. coli K-12 genomic DNA and cloned into a zero blunt pCR-4 TOPO vector as described in . The metQ gene, lacking the stop codon, was subcloned using oligonucleotides that included NdeI and XhoI restrictionenzyme sites, and then ligated into the pET21b(+) vector with a C-terminal 6 × -histidine tag. The cloned plasmids were expressed separately in E. coli BL21 (DE3) gold cells (EMD) at 37°C in Terrific Broth medium with 100 μg/ml ampicillin. The cells were induced at OD 600 ∼4.0 with 0.4 mm IPTG for 2 h, then harvested and stored at -80°C. For purification of mature MetQ, periplasmic extract was prepared by resuspending 10 g of cell paste in 10 ml of 40% sucrose, 10 mm Tris-HCl pH 7.5, and 1 mm EDTA, and stirred for 1 h at room temperature. The cells were then shocked by addition of 500 ml of ice-cold water. After stirring for 10 min, buffer components were added to a final concentration of 25 mm Tris pH 7.5, 150 mm NaCl, and 17 mm imidazole. The resulting suspension was then centrifuged at 37 500 g for 30 min to remove all cellular debris from the periplasmic extract. MetQ was isolated from the periplasmic extract by immobilized metal ion affinity chromatography using a 5 ml Ni-NTA column (GE). The affinity column was washed with 25 mm Tris pH 7.5, 150 mm NaCl, and 17 mm imidazole for 10 column volumes. Protein was then eluted from the column using 25 mm Tris pH 7.5, 100 mm NaCl and 150 mm imidazole. Peak fractions were dialyzed against 25 mm Tris pH 7.5 and 150 mm NaCl overnight, and then concentrated to 30 mg/ml using a 10kD MWCO concentrator (Millipore).
The full-length protein cloned for this work, including the signal sequence and the C-terminal 6 × -his tag, has the sequence: and maltose (Oldham and Chen, 2011) transporters. While the corresponding complex between liganded SBP and the methionine transporter is substantially less stable [K d ∼7.5 × 10 -5 m (Lewinson et al., 2010) ] than the complex in the presence of ATP measured in this work (K d ∼10 -6 m), at the protein concentrations (∼10 -4 m) used in crystallization trials, perhaps this state of the MetNIQ complex could also be crystallized under appropriate conditions.
The role of transported ligand in complex formation is of great mechanistic interest. For complex formation between MetNI and MetQ, the difference in dissociation constants between unliganded (27 nm) and liganded (1100 nm) MetQ implies that the binding of methionine to MetQ in complex with MetNI is ∼40-fold weaker than the binding of methionine to MetQ alone. Energetically, this observation is consistent with a model where the SBP must release ligand for transport to occur. The detailed energetics will certainly depend on the transporter and assay conditions; for example, while liganded maltose binding protein has been reported to more efficiently stimulate ATP hydrolysis of maltose transporter reconstituted into proteoliposomes (Davidson et al., 1992) , ligand-free maltose binding protein binds 5-fold more tightly than liganded binding protein to maltose The cleaved signal sequence is highlighted in bold, so that the purified protein used in this study consists of residues 17-279, of which residues 29-273 (underlined) are observed in the electron density.
Purification of MetNI
Purification of wild type and mutant E166Q MetNI was carried out as described (Johnson et al., 2012) with the one modification that buffer containing 20 mm TAPS pH 8.5, 100 mm NaCl and 0.025% DDM (with varying amounts of imidazole) was used in all purification steps (the original protocol used 250 mm NaCl and different detergents).
MetQ crystallization and structure determination
Crystallization conditions for MetQ were screened with varying concentrations of protein from 15 mg/ml to 60 mg/ml. Crystals were obtained using a hanging drop vapor diffusion method at 20°C, by mixing 1 μl of protein to 1 μl of the following well solution: 24% PEG 4000, 4% PEG 400, 0.1 m sodium citrate pH 5.6, and 0.2 m ammonium acetate at 30 mg/ml of protein, similar to the conditions originally described (Kadaba, 2008) . Initial thin needle crystals appeared within a week but crystals were not large enough for data collection. Both microseeding and macroseeding were used to obtain larger crystals, reaching a final size of 0.5 × 0.2 × 0.1 mm 3 in a week. The best crystal was obtained by macroseeding with a precipitant 20% PEG 4000, 3% PEG 400, 0.1 m sodium citrate pH 5.6, and 0.2 m ammonium acetate. Diffraction data to 1.6 Å resolution were collected at the Stanford Synchrotron Radiation Lightsource (SSRL) on Beamline 12-2. The data was processed using xia2 (Winter, 2010) with XDS (Kabsch, 2010) , XSCALE, and AIMLESS (Evans, 2006) , with data collection and processing statistics listed in Table 1 . Molecular replacement was performed using Phenix (Adams et al., 2010 ) from the previously solved 1.8 Å resolution MetQ structure (Kadaba, 2008 ) that was in turn solved by molecular replacement from PDB entry 1P99 (Williams et al., 2004) , a Gly-Met-binding protein. The structure was refined with Phenix to 1.6 Å resolution to a final R/R-free of 0.154/0.183. Coordinates and structure factors have been deposited in the Protein Data Bank of the Research Collaboratory for Structural Bioinformatics, with ID 4YAH.
Screening of substrate-binding deficient MetQ mutants
Individual residues located in the substrate-binding pocket of MetQ were substituted with alanine by site-directed mutagenesis using the Quickchange Mutagenesis kit (Stratagene), with the exception of Glu42, which was substituted with glutamine to avoid aggregation. To evaluate the binding ability of each mutant for substrate, L-methionine was exchanged with L-selenomethionine, and the amount of selenium was measured using inductively coupled plasma mass spectrometry (ICP-MS).
To exchange L-methionine with L-selenomethionine, individual MetQ mutants immobilized onto Ni-NTA columns were unfolded by washing with 12 column volumes of denaturing buffer containing 6 m guanidine-HCl, 25 mm Tris pH 7.5, 150 mm NaCl at the rate of 1.5 ml/ min to remove bound L-methionine. To refold MetQ, guanidine-HCl was slowly removed by flowing renaturation buffer (2 mm L-selenomethionine, 25 mm Tris pH 7.5, 150 mm NaCl) over the column at 1 ml/min for 90 min. The column was further washed with 10 column volumes of renaturation buffer to ensure reloading of MetQ with L-selenomethionine. This was followed by 12 column volumes of wash buffer (25 mm Tris pH 7.5 and 150 mm NaCl) to remove unbound L-selenomethionine. Finally, MetQ was eluted in 25 mm Tris pH 7.5, 150 mm NaCl, and 150 mm imidazole, and run over a size-exclusion column (Superdex 200 16/60, GE Healthcare) equilibrated in 25 mm Tris, pH 7.5 and 150 mm NaCl. The monodisperse peak was collected and concentrated to 20 mg/ml using an Amicon 10-kD MWCO concentrator (Millipore). The amount of bound L-selenomethionine was measured by quantitation of the selenium content of acid-digested protein samples using ICP-MS. A final concentration of 0.1 μm of protein was digested with 2% trace metal grade nitric acid (Fluka) at 70°C overnight. Samples were centrifuged at 30 000 g for 10 min using a bench top centrifuge to remove particulate matter. The supernatant was then diluted to a final volume of 5 ml in double distilled H 2 O and measured for Se 78 with an HP 4500 ICP-MS instrument. L-selenomethionine powder stock (Anatrace) was used to prepare standards. Each sample was measured in duplicate in two independent experiments. Error bars represent standard deviation. Data were processed and graphed using Microsoft Excel and Sigmaplot 11.0, respectively.
Qualitative determination of complex formation
MetNI and MetQ concentrations were measured using a NanoDrop 2000 Spectrophotometer (Thermo Scientific), according to their calculated extinction coefficients for a 1 mg/ml solution at 280 nm of 0.64 and 0.73, respectively. Complex formation was assessed by mixing E166Q MetNI transporter and its cognate binding protein, MetQ, at a molar ratio of 1:1.25 (MetNI: MetQ) in the presence of 1 mm ATP and 1 mm EDTA. The mixture, containing 40 μm MetNI, 50 μm MetQ, 1 mm ATP, 1 mm EDTA, 20 mm TAPS pH 8.5, 100 mm NaCl, 0.025% DDM, and 5 mm β-mercaptoethanol, was incubated for 1 h at room temperature and ultracentrifuged at 200 000 g for 20 min to remove any aggregation. Samples were injected onto a Superdex S200 10/300 sizing column (GE Healthcare) equilibrated with buffer containing 20 mm TAPS pH 8.5, 100 mm NaCl, 0.5 mm ATP, 1 mm EDTA, 0.3% Cymal-5, and 5 mm β-mercaptoethanol. The absorbance reading at 280 nm and the retention volume of the peak were used to follow complex formation. MetNIQ complex formation was verified by analyzing the highest peak by BN PAGE (Reisinger and Eichacker, 2006) using 4-20% Criterion gels (Bio-Rad). Two independent experiments were conducted per condition.
Measurement of MetNIQ complex dissociation constant
The E. coli MetQ sequence contains one cysteine residue at amino acid position 23. Purified wild type MetQ and N229A MetQ were labeled with Cy3-maleimide (GE Healthcare), according to the manufacturer's instructions, in buffer containing 25 mm Tris pH 7.5, 150 mm NaCl, and 10 mm TCEP pH 7.5. Unreacted dye was removed using a Superdex 200 10/300 GL column (GE Healthcare) equilibrated with the aforementioned buffer condition. The label to protein ratio was determined using a NanoDrop 2000 Spectrophotometer (Thermo Scientific) at 550 and 280 nm, and a labeling efficiency of 10% was calculated. Fluorescence measurements were performed on a Monolith NT.115 Instrument (NanoTemper Technologies GmbH) at 25°C using standard capillaries. Varying concentrations (ranging from 1.95 nm to 32 μm) of unlabeled E166Q MetNI in ATP buffer (1 mm ATP, 1 mm EDTA, 20 mm TAPS pH 8.5, 100 mm NaCl, and 0.3% Cymal-5) were titrated against a constant concentration of MetQ (101 nm of wild type MetQ or 99 nm of N229A MetQ). Fluorescent intensity as a function of E166Q MetNI concentration was normalized to fraction bound by averaging the intensity values for the lowest three concentrations of E166Q MetNI per experiment. This background intensity was subtracted from all concentrations to yield corrected intensity values. The corrected intensity values were then divided by the corrected intensity at the highest concentration of E166Q MetNI to normalize intensity values to fraction bound values. Dissociation constants for wild type MetQ or N229A MetQ binding to E166Q MetNI were calculated using the K d Fit function of the NanoTemper Analysis 1.5.41 software. Three independent MST measurements per condition were conducted, and error bars represent standard error of the mean.
